lobbying_activities: 2303007

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2303007	a586770b-16f2-46ba-8380-4b0324d2d0ba	Q2	CONNECT 4 STRATEGIES, LLC	401103720	AKCEA THERAPEUTICS, INC.	2019	second_quarter	PHA	FDA drug approval issues	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	45000		0	0	2019-07-14T14:39:46.793000-04:00